Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.43
-0.02 (-0.31%)
Dec 5, 2025, 4:00 PM EST - Market closed
Aura Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 408 | 411 | 436 | 389 | 496 | - | |
| Market Cap Growth | -10.56% | -5.92% | 12.22% | -21.59% | - | - | |
| Enterprise Value | 264 | 255 | 308 | 298 | 631 | - | |
| Last Close Price | 6.43 | 8.22 | 8.86 | 10.50 | 16.98 | - | |
| PB Ratio | 2.59 | 2.70 | 1.93 | 1.99 | 3.26 | - | |
| P/TBV Ratio | 2.61 | 2.70 | 1.93 | 1.99 | 3.26 | - | |
| Debt / Equity Ratio | 0.11 | 0.12 | 0.09 | 0.11 | 0.01 | - | |
| Quick Ratio | 8.60 | 10.13 | 18.30 | 18.06 | 20.27 | 6.54 | |
| Current Ratio | 9.04 | 10.77 | 18.76 | 18.81 | 20.90 | 6.94 | |
| Return on Equity (ROE) | -64.27% | -46.01% | -36.26% | -33.78% | -41.07% | -88.60% | |
| Return on Assets (ROA) | -35.84% | -27.46% | -22.18% | -19.63% | -24.19% | -46.92% | |
| Return on Capital (ROIC) | -38.49% | -28.87% | -23.00% | -20.39% | -25.52% | -55.32% | |
| Return on Capital Employed (ROCE) | -66.20% | -57.40% | -35.00% | -28.20% | -23.10% | -114.20% | |
| Earnings Yield | -26.07% | -21.17% | -17.51% | -15.11% | -7.11% | - | |
| FCF Yield | -21.75% | -19.74% | -14.79% | -14.32% | -6.96% | - | |
| Buyback Yield / Dilution | -15.97% | -25.32% | -32.34% | -480.18% | -1305.21% | -8.54% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.